Trials / Unknown
UnknownNCT02436291
Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- MB Mazor Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Open label study to evaluate the efficacy of CURE-EX device in the treatment of onychomycosis.
Detailed description
Each affected nail will be treated twice daily for 24-30 weeks. Efficacy will be evaluated by measuring the growth of healthy nail.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CURE-EX device | Treatment with CURE-EX device twice daily for 24-30 weeks. |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-05-06
- Last updated
- 2015-05-06
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02436291. Inclusion in this directory is not an endorsement.